References
- Bain B, Forster T, Sleigh B. Heparin and the activated partial thromboplastin time — A difference between in-vitro and in-vivo effects and the implications for the therapeutic range. Am J Clin Pathol 1980; 74: 668–673
- Brill-Edwards P, Ginsberg J, Johnston M, Hirsh J. Establishing a therapeutic range for heparin therapy. Ann Int Med 1993; 119: 104–109
- Favaloro E, Grispo L. Comparative evaluation of 17 Commercial APTT reagents. Aust J Med Sci 1994; 15: 133–140
- Hirsh J. Anticoagulant therapy in venous thromboembolism. Balliere's Clin Hematol 1990; 3: 685–692
- Chiu HM, Hirsh J, Yung WL, Regoeczi E, Gent M. Relationship between the anticoagulent and antithrombotic effects of heparin in experimental venous thrombosis. Blood 1977; 49: 171–184
- Basu D, Gallus A, Hirsh J, Cade J. A prospective study of the value of monitoring heparin therapy with the APTT. N Engl J Med 1972; 287: 324–327
- Hull, R, Raskob, GE, Hirsh, J, Jay, RM, Leclerc, JR, Geerts, WH, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal vein thrombosis. N Engl J Med 1986; 315: 1109–1114
- Hull, R, Raskob, GE, Rosenbloom, D, Panju, AA, Brill-Edwards, P, Ginsberg, JS, et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990; 322: 1260–1264
- Turpie, AG, Robinson, JG, Doyle, DJ, Mulji, AS, Mishkel, GJ, Sealey, BJ, et al. Comparison of high dose with low dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural myocardial infarction. N Engl J Med 1989; 320: 352–357
- Brandt JT, Triplett DA. Laboratory Monitoring of heparin. Effect of reagents and instruments on the activated partial thromboplastin time. Am J Clin Pathol 1981; 76: 530–537
- Zanke B, Shojania AM. Comparison of two APTT methods of monitoring heparin therapy. Am J Clin Pathol 1990; 93: 684–689
- van den Bessalaar AMJH, Meeuuwisse-Braun J, Bertina RM. Monitoring heparin therapy: relationships between the activated partial thromboplastin time and heparin assays based on ex vivo heparin samples. Thromb Hemost 1990; 63: 16–23
- Scialla SJ. Heparin monitoring by activated partial thromboplastin time. Comparison of ex vivo measurement and in vitro standardisation. Am J Clin Pathol 1985; 84: 351–354
- Gallus AS, Hirsh J, Gent M. Relevance of preoperative and postoperative blood tests in postoperative leg vein thrombosis. Lancet 1973; ii: 805–809
- College of American Pathologists. Comprehensive Coagulation Survey, 1995 Set GC2-A. Participant Summary
- Reed SV, Haddon ME, Denson KW. An attempt to standarise the APTT for heparin monitoring, using the P.T. ISI/INR system of calibration. Results of a 13 centre study. Thromb Res 1994; 74: 515–522
- Van der Velde EA, Poller L. The APTT monitoring of heparin — The ISTH/ICSH Collaborative Study. Thromb Hemost 1995; 73: 73–81